JP Stock MarketDetailed Quotes

4521 Kaken Pharmaceutical

Watchlist
  • 4237.0
  • +31.0+0.74%
20min DelayMarket Closed Dec 20 15:30 JST
194.65BMarket Cap19.92P/E (Static)

Kaken Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kaken Pharmaceutical H1 FY2025 Earnings Date

Currency：JPYNov 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
51.37B
--
+42.03%
EPS
--
377.23
--
+248.71%
Analyst Rating
Buy

Nov 18, 2024

Kaken Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 7, 20242025/Q118.254B / ----
Feb 6, 20242024/Q318.514B / ----
Aug 4, 20232024/Q118.150B / ----
Feb 3, 20232023/Q318.754B / ----
Aug 3, 20222023/Q118.197B / ----
DatePeriodRevenue/EstimateEarnings Call
Aug 7, 20242025/Q118.254B / ----
Feb 6, 20242024/Q318.514B / ----
Aug 4, 20232024/Q118.150B / ----
Feb 3, 20232023/Q318.754B / ----
Aug 3, 20222023/Q118.197B / ----

Unlock Free Earnings Estimates

Kaken Pharmaceutical Earnings Reports

  • Kaken Pharmaceutical: Confirmation letter

    Nov 13 12:25

  • Kaken Pharmaceutical: Interim report - 105th period (2024/04/01-2025/03/31)

    Nov 13 12:24

  • Kaken Pharmaceutical: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (consolidated)

    Nov 8 14:30

  • Kaken Pharmaceutical: Announcements of individual stocks regarding revisions to financial estimates and dividend forecasts (special dividends).

    Aug 7 14:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 18, 2024

    Buy

    • Strong Buy

      0.00%

    • Buy

      50.00%

    • Hold

      50.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Price
    % Chg

    No Data